Berenberg Bank downgraded shares of Smith & Nephew (NYSE:SNN – Free Report) from a buy rating to a hold rating in a research note released on Wednesday morning, Marketbeat Ratings reports.
A number of other brokerages have also issued reports on SNN. Deutsche Bank Aktiengesellschaft lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. StockNews.com raised shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Monday, August 5th. Three analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Smith & Nephew presently has a consensus rating of “Moderate Buy”.
View Our Latest Analysis on SNN
Smith & Nephew Trading Down 1.7 %
Institutional Investors Weigh In On Smith & Nephew
Large investors have recently modified their holdings of the stock. Brandes Investment Partners LP boosted its stake in Smith & Nephew by 20.5% during the second quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider’s stock worth $34,002,000 after acquiring an additional 233,293 shares in the last quarter. River Road Asset Management LLC bought a new stake in Smith & Nephew during the third quarter worth about $38,588,000. Bank of Montreal Can boosted its stake in Smith & Nephew by 355.8% during the second quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock worth $31,059,000 after acquiring an additional 964,762 shares in the last quarter. Hsbc Holdings PLC boosted its stake in Smith & Nephew by 18.9% during the second quarter. Hsbc Holdings PLC now owns 548,691 shares of the medical equipment provider’s stock worth $13,607,000 after acquiring an additional 87,360 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in Smith & Nephew by 58.2% during the second quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider’s stock worth $12,995,000 after acquiring an additional 193,046 shares in the last quarter. Institutional investors own 25.64% of the company’s stock.
About Smith & Nephew
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
See Also
- Five stocks we like better than Smith & Nephew
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Dividend Capture Strategy: What You Need to Know
- MarketBeat Week in Review – 11/4 – 11/8
- Health Care Stocks Explained: Why You Might Want to Invest
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.